[1] |
ELBORN JS. Cystic fibrosis[J]. Lancet, 2016, 388(10059): 2519-2531. DOI: 10.1016/S0140-6736(16)00576-6.
|
[2] |
REY MM, BONK MP, HADJILIADIS D. Cystic fibrosis: emerging understanding and therapies[J]. Annu Rev Med, 2019, 70:197-210. DOI: 10.1146/annurev-med-112717-094536.
|
[3] |
WIENCEK JR, LO SF. Advances in the diagnosis and management of cystic fibrosis in the genomic era[J]. Clin Chem, 2018, 64(6):898-908. DOI: 10.1373/clinchem. 2017.274670.
|
[4] |
ROSENBLATT RL. Lung transplantation in cystic fibrosis[J]. Respir Care, 2009, 54(6):777-787. doi: 10.4187/002013209790983197
|
[5] |
RATJEN F, DÖRING G. Cystic fibrosis[J]. Lancet, 2003, 361(9358):681-689. doi: 10.1016/S0140-6736(03)12567-6
|
[6] |
KEREM B, ROMMENS JM, BUCHANAN JA, et al. Identification of the cystic fibrosis gene: genetic analysis[J]. Science, 1989, 245(4922):1073-1080. doi: 10.1126/science.2570460
|
[7] |
FARRELL PM, WHITE TB, REN CL, et al. Diagnosis of cystic fibrosis: consensus guidelines from the cystic fibrosis foundation[J]. J Pediatr, 2017, 181S:S4-S15. DOI: 10.1016/j.jpeds.2016.09.064.
|
[8] |
DE BOECK K, ZOLIN A, CUPPENS H, et al. The relative frequency of CFTR mutation classes in European patients with cystic fibrosis[J]. J Cyst Fibros, 2014, 13(4):403-409. DOI: 10.1016/j.jcf.2013.12.003.
|
[9] |
SINGH M, REBORDOSA C, BERNHOLZ J, et al. Epidemiology and genetics of cystic fibrosis in Asia: in preparation for the next-generation treatments[J]. Respirology, 2015, 20(8):1172-1181. DOI: 10.1111/resp.12656.
|
[10] |
CASTELLANI C, CUPPENS H, MACEK M JR, et al. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice[J]. J Cyst Fibros, 2008, 7(3):179-196. DOI: 10.1016/j.jcf.2008.03.009.
|
[11] |
MORRAL N, BERTRANPETIT J, ESTIVILL X, et al. The origin of the major cystic fibrosis mutation (delta F508) in European populations[J]. Nat Genet, 1994, 7(2):169-175. doi: 10.1038/ng0694-169
|
[12] |
BELL SC, MALL MA, GUTIERREZ H, et al. The future of cystic fibrosis care: a global perspective[J]. Lancet Respir Med, 2020, 8(1):65-124. DOI: 10.1016/S2213-2600(19)30337-6.
|
[13] |
SANTI C, GREENE CM. Challenges facing microRNA therapeutics for cystic fibrosis lung disease[J]. Epigenomics, 2020, 12(3): 179-181. DOI: 10.2217/epi-2019-0395.
|
[14] |
DAVIS PB. Cystic fibrosis since 1938[J]. Am J Respir Crit Care Med, 2006, 173(5):475-482. doi: 10.1164/rccm.200505-840OE
|
[15] |
MURPHY KP, MAHER MM, O'CONNOR OJ. Imaging of cystic fibrosis and pediatric bronchiectasis[J]. AJR Am J Roentgenol, 2016, 206(3):448-454. DOI: 10.2214/AJR.15.14437.
|
[16] |
LEWIS PA, MORISON S, DODGE JA, et al. Survival estimates for adults with cystic fibrosis born in the United Kingdom between 1947 and 1967. the UK CysticFibrosis Survey Management Committee[J]. Thorax, 1999, 54(5):420-422. doi: 10.1136/thx.54.5.420
|
[17] |
SHEN Y, LIU J, ZHONG L, et al. Clinical phenotypes and genotypic spectrum of cystic fibrosis in Chinese children[J]. J Pediatr, 2016, 171:269-276. DOI: 10.1016/ j.jpeds.2015.12.025.
|
[18] |
SAVANT AP, MCCOLLEY SA. Cystic fibrosis year in review 2018, part 1[J]. Pediatr Pulmonol, 2019, 54(8):1117- 1128. DOI: 10.1002/ppul.24361.
|
[19] |
MARTINIANO SL, TOPRAK D, ONG T, et al. Highlights from the 2017 North American Cystic Fibrosis Conference[J]. Pediatr Pulmonol, 2018, 53(7):979-986. DOI: 10.1002/ppul.24000.
|
[20] |
RAFEEQ MM, MURAD HAS. Cystic fibrosis: current therapeutic targets and future approaches[J]. J Transl Med, 2017, 15(1):84. DOI: 10.1186/s12967-017-1193-9.
|
[21] |
STRUG LJ, STEPHENSON AL, PANJWANI N, et al. Recent advances in developing therapeutics for cystic fibrosis[J]. Hum Mol Genet, 2018, 27(R2):R173-R186. DOI: 10.1093/hmg/ddy188.
|
[22] |
CHAMBERS DC, CHERIKH WS, GOLDFARB SB, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-fifth adult lung and heartlung transplant report-2018; focus theme: multiorgantransplantation[J]. J Heart Lung Transplant, 2018, 37(10):1169-1183. DOI: 10.1016/j.healun.2018.07.020.
|
[23] |
RAMOS KJ, QUON BS, HELTSHE SL, et al. Heterogeneity in survival in adult patients with cystic fibrosis with FEV1 < 30% of predicted in the United States[J]. Chest, 2017, 151(6):1320-1328. DOI: 10.1016/j.chest.2017.01.019.
|
[24] |
WEILL D, BENDEN C, CORRIS PA, et al. A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation[J]. J Heart Lung Transplant, 2015, 34(1):1-15. DOI: 10.1016/j.healun.2014.06.014.
|
[25] |
HIRCHE TO, KNOOP C, HEBESTREIT H, et al. Practical guidelines: lung transplantation in patients with cystic fibrosis[J]. Pulm Med, 2014:621342. DOI: 10.1155/2014/621342.
|
[26] |
SNELL G, REED A, STERN M, et al. The evolution of lung transplantation for cystic fibrosis: a 2017 update[J]. J Cyst Fibros, 2017, 16(5):553-564. DOI: 10.1016/j.jcf. 2017.06.008.
|